ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. By exploiting an important new biological target underlying the disease, they hope to make great strides in treating ALS and other related neurodegenerative disorders such as Dementia, Alzheimer's Disease and Parkinson's Disease.
View Top Employees from ImStar Therapeutics Inc.| Website | http://www.imstartx.com |
| Revenue | $1 million |
| Funding | $1.8 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2012 |
| Address | 1285 West Broadway, Suite 600, Vancouver, British Columbia V6H 3X8, CA |
| Phone | (604) 551-6782 |
| Technologies | |
| Industry | Biotechnology, Neuroscience, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Neurology, Therapeutics, ALS, Health Care |
| Web Rank | 26 Million |
| Keywords | Leading Biotech Companies Nuredegenerative Disease, Imstar Therapeutics Inc. |
| Competitors | Adverum Biotechnologies, Envisia Therapeutics, Knopp Neurosciences, MatTek Life Sciences, Ocular Therapeutix, Inc. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular ImStar Therapeutics Inc. employee's phone or email?
ImStar Therapeutics Inc. Questions
The ImStar Therapeutics Inc. annual revenue was $1 million in 2024.
Agnes Chan is the COO of ImStar Therapeutics Inc..
3 people are employed at ImStar Therapeutics Inc..
ImStar Therapeutics Inc. is based in Vancouver, British Columbia.
The NAICS codes for ImStar Therapeutics Inc. are [54, 5417, 54171, 541, 541714].
The SIC codes for ImStar Therapeutics Inc. are [87, 873].
Top ImStar Therapeutics Inc. Employees
Related Companies
